For the year ending 2025-12-31, KBLB has $2,565,540 in assets. $10,564,498 in debts. $1,790,236 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 1,790,236 | |||
| Inventory | 29,067 | |||
| Prepaid expenses | 49,338 | |||
| Total current assets | 1,868,641 | |||
| Property and equipment, net | 25,003 | |||
| Investment in gold bullions (cost 241,120 and 450,216, respectively) | 494,259 | |||
| Operating lease right-of-use asset, net | 170,463 | |||
| Security deposit | 7,174 | |||
| Total assets | 2,565,540 | |||
| Accounts payable and accrued expenses-Nonrelated Party | 505,111 | |||
| Note payable - related party-Related Party | 1,492,000 | |||
| Royalty agreement payable - related party-Related Party | 65,292 | |||
| Accounts payable and accrued expenses-Related Party | 8,330,933 | |||
| Operating lease liability, current | 51,909 | |||
| Total current liabilities | 10,445,245 | |||
| Operating lease liability, net of current | 119,253 | |||
| Total liabilities | 10,564,498 | |||
| Preferred stock value-Series APreferred Stock | 5,237,800 | |||
| Common stock value-Common Class A | 31,015,428 | |||
| Common stock issuable, 1,122,311 and 1,122,311 shares, respectively | 22,000 | |||
| Additional paid-in capital | 12,434,886 | |||
| Accumulated deficit | -56,709,072 | |||
| Total stockholders deficit | -7,998,958 | |||
| Total liabilities and stockholders deficit | 2,565,540 | |||
Kraig Biocraft Laboratories, Inc. (KBLB)
Kraig Biocraft Laboratories, Inc. (KBLB)